Epidemiologic studies associate low serum vitamin D levels with an increased risk of colon cancer and inflammatory diseases such as inflammatory bowel disease (IBD 
Introduction
Colorectal cancer is the third most commonly diagnosed cancer in both men and women (1) . Studies indicate that diet and lifestyle choices play a significant role in the development of and prognosis of colon cancer (2) . Vitamin D status of an individual is also influenced by both diet and lifestyle (3) . The link between vitamin D and colon cancer was first suggested by Garland and colleagues who observed that populations residing in the northeastern United States had an increased incidence of colon cancer-related mortality compared with those living in the southern United States (4) . Since then, adequate serum vitamin D levels have been associated with decreased incidence of colon cancer and decreased mortality in patients diagnosed with colon cancer (5, 6) . Adequate serum vitamin D levels also correlate with reduced risk for developing inflammatory diseases, such as Crohn's disease, a risk factor for colon cancer (3, 7) .
The risk of colon cancer is increased in patients diagnosed with IBD (Crohn's disease or ulcerative colitis) compared with the general population, supporting the notion that colonic inflammation affects cancer development (8) . The chronic inflammation seen in IBD, likely due in part to dysregulated mucosal immune responses to enteric antigens (8) , is believed to progress to cancer through the promotion of angiogenesis, tumor-promoting cytokine production, tumor cell-invasive behavior and cellular proliferation (9) .
Vitamin D has a protective effect against colon cancer in various mouse models (10, 11) . However, these cancer models, such as Apc Min/þ mice or mice given a chemical mutagen such as azoxymethane (AOM), are not driven by inflammation (12) (13) (14) (15) . Currently, the protective effect of vitamin D on inflammation-associated colon cancer is not known.
To investigate the potential chemopreventive effects of elevated dietary vitamin D on inflammation-associated colon cancer, we utilized Smad3 À/À (Smad3 tm1Par /J) mice, which have defective TGFb signaling due to the absence of the transcription factor Smad3 (16) . In humans, the TGFb signaling pathway is commonly mutated in colon cancer, including colitis-associated colorectal cancer (17) . After being infected with an enteric microorganism, Helicobacter bilis (16) 
Materials and Methods
Mice and diets Study mice were colony-bred 129-Smad3 tm1Par /J (Smad3 À/À ) mice (age 6-14 weeks) housed in a specific pathogen-free facility. Mice were screened for rodent pathogens as previously described (18) except that sentinels were collected three times yearly rather than quarterly. In addition to referenced pathogens, annual screens were performed for minute virus of mice, lymphocytic choriomeningitis virus, and ectromelia virus.
Mice were maintained in a Helicobacter and Mouse Norovirus-free colony as previously described (19) . The mice were group housed in ventilated cages and fed a purified, irradiated diet with 1 IU vitamin D (5SRH, maintenance), 5 IU vitamin D (5AAA, high vitamin D), or 0 IU vitamin D per gram (5AV4, AIN93Null). All diets were manufactured by PMI Nutrition International (LabDiet/TestDiet) based on AIN93M diet that is formulated for the maintenance of rodents' health. All animal procedures were approved by the University of Washington Institutional Animal Care and Use Committee.
Experimental design
While no age-associated alterations in endpoint disease have been noted in our experience with Smad3 À/À mice, care was taken to evenly distribute mice across treatment groups with regard to age and sex. Independent studies were performed to evaluate the effects of high and low dietary vitamin D levels on cancer. For high vitamin D studies, mice were started on either maintenance or high vitamin D diets one week before infection. For vitamin D-deficient studies, maintenance or AIN93Null diets were initiated two weeks before infection ( Supplementary Fig. S1 ). For each diet, mice were infected with either approximately 2 Â 10 7 CFU Hb in Brucella broth or Brucella broth alone (controls) by oral gavage as previously described (Supplementary Fig. S1 ; ref. 16 ). Helicobacter infection status was monitored by fecal PCR using previously published primer sequences (18) . Fecal samples were collected at 3, 6, and 14 days postinfection for subjective fecal scoring and at 7 days postinfection for fecal cytokine analysis. Mice were weighed weekly and monitored at least three times weekly for dehydration, diarrhea, lethargy, or weight loss. Animals were euthanized by CO 2 asphyxiation at the designated end points.
Serum vitamin D and calcium determination and tissue collection
Following euthanasia, blood was obtained via cardiac puncture. Serum samples were submitted to Heartland Assays for quantification of 25-hydroxyvitamin D (radioimmunoassay) and calcium levels. Mesenteric lymph nodes, cecum, colon, and rectum were fixed in 10% phosphate-buffered formalin and processed for routine histologic examination. For study of the early inflammatory phase, cross-sections of proximal colon (5 mm) were prepared for immunohistochemistry (IHC) and histology, and cross-sections of proximal colon (5 mm) and cecum (3 mm) were stored in RNA later (Qiagen) for cytokine analysis by quantitative real-time PCR (qRT)-PCR. For evaluation of Hb colonization, 3 cm sections of mid-jejunum, proximal colon, distal colon, and whole cecum were harvested, rinsed gently in sterile PBS to remove fecal material, and stored at À20 C until DNA extraction. For fecal cytokine analysis, individual fecal samples were collected, homogenized in 250 mL RNAlater stabilization solution (Qiagen), and stored at À80
C until RNA extraction. At the time of collection, a subjective fecal score was assigned to each animal, ranking presence of diarrhea and blood in the stool as a clinical measure of IBD (20) .
Histopathology and immunohistochemistry
Whole colon and cecum were evaluated by a board-certified veterinary pathologist (P.M. Treuting) blinded to experimental groups to assess the severity of colitis and incidence of neoplasia. An overall IBD score was determined as described (21) with the exceptions that scores were summed from cecum, proximal, mid, and distal colons and none were weighted. Analysis of the rectum was included with the distal colon. IBD scores incorporate the severity of mucosal epithelial changes, degree of inflammation, and extent of lesions. A dysplasia score was also generated by determining the degree of dysplasia present in each of four segments as described (22) : cecum, proximal colon, mid colon, and distal colon. For each segment, a score ranging from 0-4 was assigned: 0, none; 1, indefinite; 2, low grade; 3, high grade; and 4, high grade with frank invasion beyond tunica muscularis and distinguished from mucosal herniation. Cancers were classified as adenocarcinomas and mucinous adenocarcinomas (16, 22) . The four individual segmental scores were summed to generate the overall dysplasia score for each animal.
For study of the early inflammatory phase, colonic expression of CD3, F4/80, cleaved caspase-3, and MHCII were evaluated on transverse cross-sections of proximal colon in animals euthanized 1 week postinfection. IHC staining within the mucosa, excluding any gastrointestinal lymphoid tissue, was scored by a pathologist blinded to groups (P.M. All IHC staining was performed by Experimental Histopathology Services at Fred Hutchinson Cancer Research Center (Seattle, WA). Rat monoclonal antibodies were used to detect MHC class II (I-A/I-E, BD Pharmingen), CD3 (MCA1477, Serotec), and F4/80 (MCA497, Serotec). Signals were detected using biotinylated goat anti-rat (Jackson ImmunoResearch) followed by streptavidin HRP (Jackson ImmunoResearch). Cleaved caspase-3 antibody (Biocare Medical CP229B) was followed by Mach 2 anti-rabbit HRP-labeled polymer (Biocare Medical RHRP520L). Staining was visualized with 3,3 0 -diaminobenzidine (Dako) and counterstained with hematoxylin (Dako). Concentration-matched isotype control slides were run for each tissue sample (Jackson ImmunoResearch).
Cytokine analysis and Helicobacter quantification by quantitative real-time PCR analysis
For cytokine analysis, RNA was extracted from cecum, colon, and feces using the RNeasy Kit (Qiagen). Fecal RNA samples were further concentrated using the Qiagen mini-elution/cleanup kit. RNA was converted to cDNA using SuperScript First Strand Synthesis System (Invitrogen) followed by qRT-PCR using Power Sybr Green Master Mix (Applied Biosystems) and a Stratagene Mx3005P analyzer (Agilent Technologies). Samples were run in duplicate. Cytokine levels were normalized to hypoxanthine-guanine phosphoribosyltransferase (HPRT) and expressed relative to a control sample (RNA from cecum or proximal colon) that was run on every plate as a calibrator. For Helicobacter quantification, DNA was extracted from mid-jejunal, cecal, proximal colon, and distal colon samples using a previously published protocol (23) . Primer sequences used are outlined in Supplementary Table S1 . Data were analyzed using Stratagene's MxPro v4.10 software (Agilent Technologies).
Epithelial and lamina propria cell preparations
Proximal colon (4 cm sections) samples were rinsed in PBS to remove fecal material, and epithelial and lamina propria leukocyte (LPL) populations were isolated using the Lamina Propria Dissociation Kit and gentleMACS Dissociator according to manufacturer's instructions (Miltenyi Biotec). Cells were pelleted, snap-frozen in liquid nitrogen, and stored at À80 C.
Western blotting
Protein was extracted by homogenizing cell pellets in RIPA buffer (Thermo Fisher Scientific) containing protease and phosphatase inhibitors (Thermo Fisher Scientific). Western blot analysis was performed according to a previously published protocol (19) with the following modifications. Proteins (40 mg/lane) were run on gradient (4%-15%) Tris-HCl polyacrylamide gels (Bio-Rad) and transferred to polyvinylidene fluoride membranes using 100 mmol/L N-cyclohexyl-3-aminopropanesulfonic acid buffer with 10% methanol. Primary antibodies used were vitamin D receptor (VDR, SC-1008; Santa Cruz Biotechnology), NFkB signaling (Phospho-NF-kB p65 (Ser536), and IkBa, L35A5; Cell Signaling Technology), MAPK signaling (Phospho-MAPK Family, 9910, and MAPK Family, 9926, Antibody sampler kits; Cell Signaling Technology), Bcl-xl (54H6; Cell Signaling Technology), and proliferating cell nuclear antigen (PCNA, PC10; Cell Signaling Technology). b-Actin (A5441; Sigma-Aldrich) was used as a loading control.
Statistical analysis
Before statistical analysis, distribution of data was assessed for normality. If data were not normally distributed, transformation was attempted; if transformation did not normalize the distribution, nonparametric tests were performed. Serum vitamin D, serum calcium, histologic scoring, fecal scoring, and densitometries were analyzed using either an unpaired or Mann-Whitney t test. qRT-PCR data were analyzed using the Kruskal-Wallis nonparametric test followed by the Dunn post hoc test to adjust for multiple comparisons. Cancer and dysplasia incidence significance was determined by the Fisher exact test. All data are presented as mean AE SEM. Differences with a P value of 0.05 or less were considered significant. All statistical analyses were performed using GraphPad Prism software (Version 5.04, GraphPad Software Inc). Treatment with increased dietary vitamin D significantly reduces cancer incidence in Hb-infected Smad3 À/À mice Hb-infected mice fed increased dietary vitamin D had a significantly reduced incidence of invasive colon cancer compared with Hb-infected mice fed maintenance diet (11% vs. 41%, P ¼ 0.0121; Fig. 1C ). No neoplastic lesions developed in uninfected mice on either diet (Fig. 1C) . Mucinous adenocarcinomas located in the proximal colon were the primary neoplasm diagnosed, as previously noted in this model ( Fig. 1D ; ref. 16 ). Well-differentiated mucinous adenocarcinomas were characterized by expansile mucin-filled, epithelial-lined cysts that disrupt the muscular tunics, serosa and expand into mesentery (Fig. 1D ). Consistent with the decreased incidence of invasive adenocarcinoma, Hb-infected mice fed high vitamin D diet had an average 4-fold decrease in dysplasia scores compared with mice fed maintenance diet (mean: 0.71 vs. 2.85, P < 0.001; score range 0-16; Fig. 1E ) with a significantly higher percentage of animals with no evidence of dysplasia (83% vs. 40%, P ¼ 0.0005). Dysplasia was primarily observed in the cecum and proximal colon. Minimal dysplasia was observed in the mid colon of mice fed maintenance diet but not in high vitamin D fed mice. No dysplasia was observed in the distal colon regardless of diet. Fig. S2C ). There was no significant difference in body weight change associated with diet following Hb infection (data not shown).
Results

Increased dietary vitamin D significantly increases
To determine whether improved clinical signs associated with increased dietary vitamin D correlate with decreased colonic inflammation during early disease, proximal colon, and cecum of mice fed high vitamin D or maintenance diet were analyzed for inflammation one week after Hb infection. Hbinfected animals fed high vitamin D diet had significantly reduced colitis compared with infected animals fed maintenance diet (mean 2.7 vs. 15.5, P < 0.0001; Fig. 2 Fig. 2 and Supplementary Fig. S3B-S3D ]. Brothtreated controls had minimal inflammation regardless of diet. Because inflammation is often associated with increased cell proliferation, we evaluated if increased dietary vitamin D was associated with changes in cell proliferation in either lamina propria or epithelial cell populations within the colon one week after Hb treatment. PCNA was used as a marker of cellular proliferation by Western blot analysis. Analysis of PCNA . Note the mucin lakes and neoplastic epithelial cells penetrating the colonic wall and proliferating within the muscularis and serosa. H&E staining; original magnification, Â20. Inset, subgross of the whole colon section; blue box, magnified region. E, Hb-infected animals fed high vitamin D diet had decreased mean dysplasia scores and an increased number of animals with no evidence of dysplasia. Ã , P < 0.01; ÃÃ , P < 0.001.
showed no significant differences associated with diet in either cell population (LPL mean 0.73 vs. 0.67, epithelial cell mean 0.99 vs. 0.85, high vitamin D diet vs. maintenance diet respectively, data not shown).
High dietary vitamin D decreases cecal, proximal colon, and fecal proinflammatory cytokines 1 week after Hb infection Because we previously observed elevated inflammatory cytokines in this model associated with Hb infection (16), proinflammatory cytokine expression in cecal and proximal colon tissues one week after Hb infection were evaluated to determine whether increased vitamin D would dampen the inflammatory response induced by infection. Increased expression of Il1b, macrophage chemotaxis factor 1a (Mip1a), Il6, Tnfa, and Ifng were noted in cecal tissue from Hb-infected animals fed maintenance diet compared with broth-treated controls (Fig. 3) as seen previously with this model (16) . However, there was a significant reduction in expression of those same cytokines in Hb-infected mice fed increased dietary vitamin D compared with those fed maintenance diet (Fig. 3A-E) . Interestingly, there were no changes in expression of the anti-inflammatory cytokine, Il10 in response to diet or Hb infection (Fig. 3F) . Expression patterns of proinflammatory cytokines in the proximal colon were similar to those observed in cecal tissue ( Supplementary Fig. S4A-S4F ).
Fecal cytokines have been used in the Hb-infected Smad3
À/À mouse model to characterize the inflammatory response and predict development of cancers (24) . To determine whether fecal cytokine expression correlated with tissue cytokine expression, expression of Il1b and Mip1a was evaluated in fecal pellets collected from animals 1, 2, and 3 weeks after Hb infection. Similar to the expression pattern of Il1b and Mip1a observed in cecal and proximal colon tissues at 1 week after infection (Fig. 3A and B and Supplementary Fig. S4A and S4B), expression of Il1b and Mip1a in feces were significantly increased in Hb-infected animals fed maintenance diet compared with broth-treated animals ( Supplementary Fig. S4G and S4H ). Accordingly, Hbinfected mice fed high vitamin D diet had an average 3-fold decrease in fecal Il1b and 1.5-fold decrease in fecal Mip1a expression compared with mice fed the maintenance diet. However, these fecal cytokine changes were transient as there were no significant differences in Il1b and Mip1a expression between any treatment group at 2 or 3 weeks after infection (data not shown).
Increased dietary vitamin D decreases p-P38 MAPK in the colon
Helicobacter species have been shown to elicit proinflammatory cytokine production through TLR4-dependent activation of the MAPK and NFkB pathways (25) . Thus, we determined whether decreased colonic inflammation in Smad3 For changes in the MAPK pathway, relative levels of protein expression of activated forms of P38 (p-P38), JNK (p-JNK), and ERK1/2 (p-ERK) in LPL and colonic epithelial cell populations were determined. LPLs of Hb-infected animals fed increased dietary vitamin D had a 7-fold decrease in p-P38 compared with maintenance diet-fed animals (P ¼ 0.012, Fig. 4A and Supplementary Fig. S5 ). Interestingly, similar changes were not detected in colonic epithelial cells (Fig. 4A and Supplementary  Fig. S5 ). There was a trend toward decreased p-JNK expression in colonic tissue from animals fed increased dietary vitamin D; however, these differences were not statistically significant (LPL: 4.5-fold decrease, P ¼ 0.14 and epithelial cells: 2-fold decrease, P ¼ 0.052; Fig. 4B and Supplementary Fig. S5 ). There were no notable differences in p-ERK1/2, total P38, or total JNK in either cell population (data not shown).
For alterations in the NFkB pathway, phosphorylated P65 (p-P65) was evaluated by Western blot analysis in LPL and epithelial cell populations. Mice fed high vitamin D diet had a 4.5-fold decrease in p-P65 in colonic epithelial cells compared with mice fed maintenance diet (P ¼ 0.028, Fig. 4C and Supplementary Fig. S5 ). We did not detect p-P65 in LPL regardless of diet while IkBa, an inhibitor of NFkB activation, To determine whether the changes in p-P38 or p-P65 were associated with decreased Tlr4 expression, qRT-PCR was performed on cecal tissues collected from mice 1 week after Hb infection. Average Tlr4 expression in Hb-infected animals was modestly increased (1.3-fold) compared with broth-treated controls (P < 0.01; Fig. 4D ). Although Tlr4 expression in Hbinfected mice was lower when fed high vitamin D diet, the difference was not statistically significant.
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High dietary vitamin D does not alter Hb colonization in
Changes in the gut microbiome or changes in bacterial load can influence disease severity in both human patients (26) and animal models of IBD (26, 27) . As Tlr4 expression levels tend to be lower in high vitamin D-fed Smad3 À/À mice following Hb infection, we determined whether vitamin D alters Hb colonization in cecum and colon where they preferentially reside (16) . qRT-PCR was used to compare the relative amount of Helicobacter organisms in cecal, proximal, and distal colonic tissues collected 8 weeks after Hb infection from mice fed either increased or maintenance levels of vitamin D. While cecal tissues had the highest concentration of Helicobacter as previously reported (16) , no significant differences in Helicobacter colonization were associated with diet ( Supplementary  Fig. S6 ).
High dietary vitamin D does not alter cecal expression of vitamin D receptor or enzymes involved in vitamin D metabolism
To determine whether the protective effect of increased dietary vitamin D was associated with changes in proteins involved in vitamin D signaling and/or metabolism, qRT-PCR was used to evaluate RNA expression of vitamin D receptor (Vdr) as well as two enzymes involved in conversion of vitamin D into its active and inactive forms, 25(OH)D 3 -1a-hydroxylase (Cyp27b1), and 1, 25(OH) 2 D 3 24 hydroxylase (Cyp24a1) in cecal tissue at one week after Hb infection. A small yet significant increase in VDR expression was detected in mice fed high vitamin D diet following Hb infection (Fig. 5A) . However, there were no changes in mRNA levels of Cyp27b1 and Cyp24a1 associated with either diet or infection status (Fig. 5B and C) . Although Vdr mRNA was altered with diet, differences in VDR protein expression were not detected using Western blot analysis of proximal colon tissue (data not shown). Because decreased serum vitamin D is associated with an increased risk for developing IBD as well as colon cancer in humans (4-7), we hypothesized that a diet deficient in vitamin D would exacerbate inflammation and potentially increase the incidence of colon tumors in Hb-infected Smad3 À/À mice. We tested this hypothesis by feeding mice maintenance diet or diet devoid of vitamin D (AIN93Null) and induced inflammation by Hb infection. Serum 25-hydroxyvitamin D levels were significantly decreased in AIN93Null-fed mice compared with mice fed maintenance diet (mean: 5.7 vs. 12.2 ng/mL, P ¼ 0.01) after 2 weeks on the diet and were below the limit of detection at the end of the 16-week study ( Fig. 6A and B) . Despite decreased serum vitamin D levels, mice maintained on AIN93Null diet showed no differences in serum calcium compared with maintenance diet-fed controls (Fig. 6C) . Clinical disease during the early inflammatory phase was assessed by monitoring subjective fecal scores and body weight change following Hb infection. Mice maintained on AIN93Null diet showed no differences in fecal scores or body weight change compared with maintenance diet-fed controls (data not shown). To determine whether decreased dietary vitamin D exacerbated IBD at early disease stages, proximal colon and cecal tissue of mice fed maintenance diet or AIN93Null were analyzed for inflammation one-week after Hb infection. There were no differences in IBD associated with diet (Fig. 6D) . To further evaluate any effect of AIN93Null diet, proinflammatory cytokine expression in proximal colon tissues was measured to determine whether decreased dietary vitamin D would exacerbate the inflammatory response induced by Hb. In correlation with the lack of effect on IBD scores, no differences were noted in cytokine gene expression associated with diet ( Supplementary Fig. S7 ). Consistent with the lack of altered inflammation early in disease, there were no differences in cancer incidence or dysplasia noted between AIN93Null-fed mice compared with maintenance diet-fed animals ( Vitamin D supplementation decreases cancer incidence in several rodent models of colon cancer (12) (13) (14) (15) . These models rely on either genetic predisposition for the development of gastrointestinal neoplasias as is the case with APC Min/þ mice or treatment with a chemical mutagen such as AOM to simulate the adenoma to carcinoma progression that occurs during the development of sporadic colon cancer (8, 29) . However, the molecular changes, disease progression, and pathology of inflammation-associated cancer are distinct from those changes observed in sporadic or familial colon cancers and therefore may influence the efficacy of vitamin D as well as mechanisms through which it promotes protection from tumor formation.
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Chronic inflammation is believed to frequently play a key role in carcinogenesis (9) . Links between inflammation and cancer have not only been observed in colon cancer in human patients with IBD (8) but also in liver, pancreatic, stomach, esophageal, and prostate cancers (9) . Several studies utilizing mouse models of colitis have shown that vitamin D can be beneficial in preventing or ameliorating inflammation and clinical disease (30) (31) (32) ; however, these models do not typically progress to neoplasia. Recently, the DSS/AOM model, another model of inflammation-associated cancer that does progress to dysplasia and tumor formation, was used to demonstrate that increasing concentrations of dietary vitamin D are protective against preneoplasic lesions in a dose-dependent manner (33) . Consistent with these findings, we have shown that increased dietary vitamin D is effective at not only preventing inflammation and dysplasia, but subsequent invasive tumor formation as well.
Chronic inflammation is associated with increased production of proinflammatory cytokines, including TNFa, IL1b, and IL6, which contribute to carcinogenesis through influences on cell proliferation, apoptosis, differentiation, and angiogenesis (34) . Dietary vitamin D supplementation significantly lowered inflammatory cytokines induced in response to Hb in Smad3 À/À mice. In human patients with colon cancer, these proinflammatory cytokines are positively associated with increased cancer growth, higher neoplastic grade, and increased risk of mortality (34) . Proinflammatory cytokines are also upregulated in patients with IBD, even before the onset and progression to dysplasia or neoplasia (35) , and vitamin D supplementation has been linked to decreased circulating proinflammatory cytokines in patients with colorectal adenomas (36) . Epidemiologic evidence suggests that treatments that limit inflammation may be beneficial in reducing the incidence of inflammation-associated colon cancer in high risk populations (37) . Together, these data suggest that dietary vitamin D may be effective at decreasing the proinflammatory milieu in patients with weeks (B) on diet. Serum calcium levels (C) were determined at 18 weeks after diet initiation. Mann-Whitney t test. Ã , P < 0.05; ÃÃ , P < 0.001. One week after Hb infection, cecum and proximal colon were histologically scored for inflammation (D). Hb-infected/maintenance diet (n ¼ 14), Hb-infected/AIN93Null diet (n ¼ 15), broth-treated/maintenance diet (n ¼ 7), and broth-treated/AIN93Null diet (n ¼ 7). Mann-Whitney t test; ÃÃ , P < 0.001. Sixteen weeks after infection, colon and cecum were analyzed for cancer incidence (E) and dysplasia (F). Incidence of no dysplasia is indicated by percent near brackets (F). Hb-infected/ maintenance diet (n ¼ 20), Hb-infected/AIN93Null diet (n ¼ 20), broth-treated/maintenance diet (n ¼ 10), and broth-treated/AIN93Null diet (n ¼ 10).
IBD and serve as a useful adjunct treatment in certain populations.
The mechanism by which vitamin D suppresses colon cancer in Smad3 À/À mice is not completely clear, although our data suggest the anti-inflammatory effects of vitamin D are important. Helicobacter species are Gram negative, microaerophilic bacteria that can induce local production of proinflammatory cytokines and chemokines through TLR4 signaling and subsequent activation of the MAPK and NFkB pathways (25) . Both of these pathways have been shown to be upregulated in human patients with IBD (38) and are thought to be important links between inflammation and cancer (38) (39) (40) . In vitro evidence suggests that vitamin D is able to suppress MAPK activity and subsequent proinflammatory cytokine production through the upregulation of MAPK phosphatase-1 (41) and NFkB signaling through the upregulation of IkBa, an inhibitor of NFkB activation (42) , or through decreased expression of the NFkB component RelB, which can lead to inhibition of dendritic cell differentiation and maturation (43) . During the early inflammatory disease phase in Hb-infected Smad3 
